Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

TB-500 Thymosin Beta-4 Fragment 17-23

This product may contain trehalose as a lyoprotectant/solubility agent. TB-500 Fragment 17-23 is the central heptapeptide fragment containing TB4's actin-binding domain. Third-party tested, USA-made, 99% purity peptide. Research use only (RUO). Product Description TB-500 Fragment 17-23 (Leu-Lys-Lys-Thr-Glu-Thr-Gln) encompasses thymosin β4's core actin-binding region for specialized research. Laboratory studies examine direct actin sequestration, polymerization inhibition, and cytoskeletal dynamics in vitro. Research applications include cell migration mechanism analysis, wound healing pathway investigations, and angiogenesis factor studies. This fragment allows researchers to isolate actin-binding functions from other TB4 activities. Studies investigate G-actin sequestration kinetics, cellular remodeling processes, and tissue repair signaling. Research protocols utilize Fragment 17-23 for structure-activity relationship studies, minimal functional domain identification, and comparative

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

This product may contain trehalose as a lyoprotectant/solubility agent.

TB-500 Fragment 17-23 is the central heptapeptide fragment containing TB4's actin-binding domain. Third-party tested, USA-made, 99% purity peptide. Research use only (RUO).

Product Description

TB-500 Fragment 17-23 (Leu-Lys-Lys-Thr-Glu-Thr-Gln) encompasses thymosin β4's core actin-binding region for specialized research. Laboratory studies examine direct actin sequestration, polymerization inhibition, and cytoskeletal dynamics in vitro. Research applications include cell migration mechanism analysis, wound healing pathway investigations, and angiogenesis factor studies.

This fragment allows researchers to isolate actin-binding functions from other TB4 activities. Studies investigate G-actin sequestration kinetics, cellular remodeling processes, and tissue repair signaling. Research protocols utilize Fragment 17-23 for structure-activity relationship studies, minimal functional domain identification, and comparative peptide biology research in controlled laboratory environments.

Peptide Specifications

SPECIFICATION DESCRIPTION Sequence Leu-Lys-Lys-Thr-Glu-Thr-Gln (LKKTETQ) Molecular Formula C36H66N10O13 Molecular Weight 846.97 g/mol CAS Number 476014-70-7 PubChem CID 10169788 Synonyms Fequesetide, TB-500, Ac-LKKTETQ, Thymosin Beta-4(17-23) Purity ≥99% (HPLC) Solubility Soluble in water and physiological buffers Storage Conditions Store at ≤6°C for short term, -20°C for long term, tightly sealed, away from light and moisture Physical Appearance White to off-white lyophilized powder Reconstitution Reconstitute in sterile water or bacteriostatic water to desired concentration Stability Lyophilized form stable at room temperature for short periods; reconstituted solution should be used promptly or stored at 4°C for short term, -20°C for long term Quality Verification Third-party tested by certified laboratory Manufacturing Standard USA-made, pharmaceutical-grade, GMP compliant Intended Application In vitro research applications only

Our Product Quality Guarantee

Every Limitless Biotech compound undergoes independent testing for endotoxins and sterility, meeting rigorous research standards through our systematic quality protocols and proactive manufacturing processes.

Buy TB-500 Fragment 17-23 From Limitless Biotech

Limitless Biotech provides USA-manufactured TB-500 Fragment 17-23 peptide for sale with verified molecular sequences and purity through comprehensive third-party testing. We ensure research quality with same-day shipping and dedicated customer support for your scientific endeavors.

Connected topics

Follow this recovery question